Vienna BioCenter is a leading life sciences location in Europe, offering a unique combination of research, education and companies on a single campus: 1,800 employees, 1,500 students, 91 research groups, and 35 biotech companies. Over the last thirty years, the Vienna BioCenter has developed into one of the leading multi-disciplinary biomedical research centers in Europe and into the premier location for Life Sciences in Austria. Its institutions and companies are among the European leaders in their field and have been able to attract excellent scientists as well as substantial private and public funding. Today, the Vienna BioCenter hosts a broad spectrum of Life Sciences players ranging from universities, basic research institutions, and biotech companies, as well as private and public service organisations, including outreach organisations and a business incubator. This type of diversity is a clear strength of the campus and very much differentiates it from all other biotech clusters in Austria and in the World. In total, the research institutions and companies at the VBC currently employ 1,800 employees incl. 260 PhD students. In addition, the Universities at the Vienna BioCenter (University of Vienna, Medical University of Vienna and FH Campus Wien) host around 1,500 Bachelor and Master students. Science at the campus is split into 96 different research groups. The therapeutic biotech companies on the campus, are specialised in vaccines, immunology and disease diagnostics. The rest of the companies offer a range of research reagents and diagnostic products or provide services for the scientific community and private customers. Currently, the Vienna BioCenter expands across 90.000m2 and counts 34 members. The working language is English. All the Vienna BioCenter members share a common vision of excellence. Evidence for this are the Vienna BioCenter Core Facilities, the VBC Lecture Series and the prestigious VBC PhD Program.